The DIPAK 1 Study: Baseline characteristics and short-term treatment effects of lanreotide versus standard care in patients with later stage ADPKD

Niek F. Casteleijn, A. Lianne Messchendorp, Edwin M. Spithoven, Hedwig M. d'Agnolo, Joost P. Drenth, Johan W. de Fijter, Dorien J. Peters, Mahdi Salih, Darius Soonawala, Folkert W. Visser, Jack F. Wetzels, Robert Zietse, Ron T. Gansevoort

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Article numberSP012
Pages (from-to)90-91
Number of pages2
JournalNephrology, Dialysis, Transplantation
Publication statusPublished - May-2016
Event53rd ERA-EDTA Congress - Vienna, Austria
Duration: 21-May-201624-May-2016

Cite this